Drugs.com - Pharma Industry News

Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors

MONDAY, Feb. 24, 2025 -- For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly lower risk for depression compared with dipeptidyl peptidase-4 inhibitor (DPP-4i) use...

Feb 25, 2025 - 00:19
 0
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
MONDAY, Feb. 24, 2025 -- For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly lower risk for depression compared with dipeptidyl peptidase-4 inhibitor (DPP-4i) use...
Read More

Tags:

Previous Article

NASA cuts off international climate science support

Next Article

2.3 Million New Female Breast Cancer Cases Seen Globally in 2022

Related Posts

Younger People Open to Self-Collected Testing for Sexually Transmitted Infections

Younger People Open to Self-Collected Testing for Sexua...

Feb 20, 2025  0

Eating Behaviors, Certain Foods Linked to Pelvic Floor Disorders

Eating Behaviors, Certain Foods Linked to Pelvic Floor ...

Feb 26, 2025  0

Mental Health Conditions Common in Pediatric Stroke Survivors

Mental Health Conditions Common in Pediatric Stroke Sur...

Feb 9, 2025  0